What Researchers Did
Researchers conducted a case series to assess the effectiveness of hyperbaric oxygen therapy (HBO2) for chronic radiation enteritis in 65 patients.
What They Found
Among 65 patients with chronic radiation enteritis, primarily presenting with bleeding (n=54), hyperbaric oxygen therapy resulted in an overall response rate of 68%. This included a complete response in 43% of patients and a partial response in 25%.
What This Means for Canadian Patients
Canadian patients suffering from chronic radiation enteritis, a difficult-to-treat complication of radiation, might find hyperbaric oxygen therapy (HBO2) to be a beneficial treatment option. This therapy could potentially alleviate symptoms like bleeding, pain, and diarrhea, improving their quality of life.
Canadian Relevance
This study has no direct Canadian connection as it was conducted at a tertiary referral academic medical center outside of Canada.
Study Limitations
A key limitation of this study is its case series design, which lacks a control group and may be subject to selection bias.